coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Rural Rother PCN, Rother · Health Inequalities Profile

    PCN U79764 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 7 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    42,940

    Registered population

    52.0% aged 18–64

    32.0%

    Aged 65+

    ICB 21.9% · England 17.9%

    3.3%

    Ethnic minority (non-White)

    0.9% Asian · England 9.6%

    6.3%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    ~2,556

    Core20 residents (est.)

    Resident basis; registered basis ~2,787 · see page 3

    9,143

    Hypertension register

    +5.83% in 3 yrs · England +5.60%

    392

    SMI register

    35.2% of Rother's

    998

    COPD register

    Reviews +13.20% in 3 yrs

    Forecast to 2030

    10,441

    Hypertension patients, 2030

    +1,298 on today

    69.7%

    QRISK ≥20% on statins, 2030

    +4.33pp over 3 yrs

    7.8%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    72.1%
    Hypertension blood pressure control exceeds national average.

    Hypertension treatment to target is 72.1% (+5.8 pp over 2023 to 2025), above Rother (69.2%), NHS Sussex ICB (69.1%) and England (70.3%).

    80.6%
    Secondary prevention statin therapy trails England.

    Statin treatment in diabetes with CVD history fell 2.2% over 2023 to 2025 to 80.6% (England 84.4%, +1.0%); QRISK ≥ 20% therapy is 60.0%.

    28.2%
    Core20 deprivation concentrated in two practices.

    Ferry Road Health Centre has 28.2% Core20 patients; Rye Medical Centre has 23.2%; Martins Oak, Fairfield, and Sedlescombe & Westfield Surgeries record 0.0%.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Of 42,940 registered patients, 32.0% are aged 65+, alongside 20 catchment care homes

    Rural Rother PCN serves 42,940 registered patients across its member practices. Older adults represent 32.0% of the list (13,741 patients aged 65+), above Rother (30.4%), NHS Sussex Integrated Care Board (21.9%), and England (17.9%). Working-age adults (18-64) form 52.0% (Rother 53.6%, ICB 60.5%, England 62.7%) and children aged 0-17 comprise 16.0% (Rother 16.1%, ICB 17.7%, England 19.6%). Based on Census usual residents rather than registered patients, 96.7% are White (Rother 95.6%, ICB 91.0%, England 81.1%), with an ethnic minority share of 3.3%. List size is projected to grow 1.7% to 2030 (Rother 2.0%, ICB 2.1%, England 2.3%; unverified methodology).

    Age profile

    0–1716.0%
    18–6452.0%
    65+32.0%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White96.7%
    Mixed1.5%
    Asian0.9%
    Black0.4%
    Other0.4%

    Older people · falls rows are Rother local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Rother LA)2,2942,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)86.3%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)59.3%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Rother LA)1,1599819552024/25
    Falls deaths, all ages, per 100,000 (Rother LA)8.414.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 6.3% overall but concentrated entirely in two practices

    Rural Rother PCN's Core20 share is 6.3%, below Rother (13.8%), NHS Sussex Integrated Care Board (9.2%), and England (21.0%), with an average IMD decile of 4.7 (England 5.5). Deprivation is concentrated in two practices: Ferry Road Health Centre records a 28.2% Core20 share (1,089 estimated patients) and Rye Medical Centre records 23.2% (1,698 estimated patients). The other five practices each record 0.0%. Inequalities outreach may achieve greater impact by prioritising Rye Medical Centre by patient volume and Ferry Road Health Centre by deprivation concentration.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Ferry Road28.2% · 1,089 patients
    Rye23.2% · 1,698 patients
    Martins Oak0.0% · 0 patients
    Fairfield0.0% · 0 patients
    Sedlescombe &0.0% · 0 patients
    Oldwood0.0% · 0 patients
    Northiam0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    392

    SMI register

    0.91% recorded prevalence

    248

    Learning disability register

    0.57% recorded prevalence

    20

    Care homes, 587 beds

    In the PCN catchment

    9.9%

    Provide unpaid care

    Rother, Census 2021

    The PCN records 392 patients with severe mental illness (0.9%, Rother 1.2%) and 248 with learning disabilities (0.6%, Rother 0.7%), alongside 20 catchment care homes (587 beds). Rother records 12 rough sleepers in 2025 and a 9.9% unpaid care rate; borough figures are not PCN headcounts. Crude register rates trailing borough benchmarks may reflect demographic differences or recording practices, which register audits could test.

    Severe mental illness: physical health checks

    Recorded severe mental illness prevalence is 0.9% (England 1.0%). For physical checks, blood pressure reached 85.0% (England 83.4%, Rother 86.9%) and BMI reached 83.8% (England 82.1%, Rother 86.2%), while alcohol recording reached 87.5% (England 81.8%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    9,143

    Hypertension register

    +5.83%

    Register growth, 3 yrs

    Rother +3.70% · England +5.60%

    +5.86pp

    BP control, under 80

    ≤140/90 · +4.68pp aged 80+

    +1,298

    More patients by 2030

    Forecast 10,441 (23.72%)

    Hypertension case-finding and control

    Hypertension prevalence is 21.2% (9,143 patients), above England (15.2%) and NHS Sussex Integrated Care Board (16.3%) but below Rother (22.0%). Register prevalence rose 1.2 pp (+5.8%) over three years (England +0.8 pp, +5.6%). Treatment to target is 72.1% (+5.8 pp over three years), outperforming England (70.3%) and Rother (69.2%). However, recent blood pressure recording is 88.6%, behind England (90.0%) and the ICB (90.2%). Practice prevalence spans from 17.6% at Northiam Surgery and 17.7% at Oldwood Surgery to 24.8% at Rye Medical Centre; crude rates are not age-adjusted. Clinical control exceeds national benchmarks; lower register prevalence relative to the borough could reflect demographic differences or case-finding variation, which audit across practices would test.

    Lipids and statins

    Statin treatment in diabetes with cardiovascular disease history fell 1.8 pp (England +0.8 pp) to 80.6%, trailing England (84.4%). Lipid-lowering therapy for QRISK ≥ 20% is 60.0%, below England (63.6%) and matching the ICB (60.0%). Fewer high-risk patients receive lipid therapy than national benchmarks imply, indicating an opportunity to prioritise secondary prevention recall audits.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026129,656£2.90£2.42£1.86£376,002
    Cardiovascular (all), 2025159,660£4.00£3.32£3.33£638,640

    In 2026, lipid-modifying drugs cost £2.90 per item across 129,656 items, exceeding England (£1.86) and NHS Sussex Integrated Care Board (£2.42), costing £134,842 more than at England's unit cost; unit costs do not establish prescribing inefficiency. Prescribing unit costs exceed benchmarks, pointing to an opportunity to review lipid-modifying drug choices alongside clinical review.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +6.25%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +2.83%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 7.0% (2,907 patients), above England (6.6%) and below Rother (7.2%). Annual asthma review coverage is 62.9% (England 65.7%, Rother 59.1%), leaving about 1,100 patients without a recorded review. Prescribing for ages 5-19 reaches 2,213 items per 1,000 (England 1,488; ICB 1,553). Conversely, COPD review coverage reached 80.0% (England 76.4%) across 998 register patients (2.3% prevalence). Elevated youth prescribing alongside review shortfalls could reflect poor control; clinical audit of pediatric reviews would test this.

    Cancer register and children's immunisation

    Cancer QOF prevalence is 6.2% (2,690 patients), compared to England (3.8%) and NHS Sussex Integrated Care Board (4.7%). In childhood immunisation coverage, 6-in-1 uptake at 12 months is 88.9% (distance to 95% coverage target: -6.1 pp) and MMR dose 1 coverage at 24 months is 89.6% (distance to 95% coverage target: -5.4 pp).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months88.9%

    England 91.0%

    6-in-1 complete primary course at 24 months94.8%

    England 92.2%

    MMR dose 1 at 24 months89.6%

    England 88.3%

    MMR dose 2 at age 592.1%

    England 82.8%

    4-in-1 pre-school booster at age 591.1%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    In 2022, 58.5% of cancers with a known stage in NHS Sussex ICB were diagnosed at stage 1 or 2 (4,799 of 8,209 cases), exceeding England (55.3%) but sitting 16.5 percentage points below the 75.0% national ambition by 2028. Reaching the ambition would require about 1,360 additional early diagnoses annually across the ICB. Staging completeness was 64.3% (England 67.0%). In primary care, PCN cervical screening coverage in ages 25-49 is 72.6% (England 66.8%), after a 1.6% three-year decline (England -1.0%). Coverage is 69.1% at Northiam Surgery and 70.4% at Ferry Road Health Centre. Staging metrics reflect system pathways, not PCN performance.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026 (provisional), East Sussex Healthcare NHS Trust achieved 84.2% on the cancer 28-day faster diagnosis standard, exceeding the 75.0% standard, NHS Surrey and Sussex Integrated Care Board (79.3%), and England (79.3%). On the 62-day referral to treatment standard, East Sussex Healthcare NHS Trust reached 67.0%, below the 85.0% standard by 18.0 pp, trailing England (71.2%) and the ICB (71.5%). Acute trust waiting times reflect secondary care operational capacity rather than primary care performance.

    Pathways within standard (%)East Sussex HealthcareMaidstone and Tunbridge WellsEast KentSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)84.2081.7871.2879.2979.32
    31-day treatment (96%)98.1998.3596.6790.4592.50
    62-day referral to treatment (85%)67.0487.4370.0171.5171.16
    Diagnostic waits over 6 weeks (%)East Sussex HealthcareMaidstone and Tunbridge WellsEast KentEngland
    MRI6.480.9247.5821.40
    CT0.480.5137.459.92
    Echocardiography21.942.5714.1728.48
    Colonoscopy0.7419.809.5830.83
    Gastroscopy0.3124.0322.1629.02
    All 15 DM01 tests5.276.4248.3823.14
    Community services activityEast Sussex residentsSurrey and Sussex ICB
    Care contacts100,740309,615
    Referrals17,28566,930
    Patients with a contact25,88085,660

    Community services (residents of East Sussex), Jun 2026 (provisional). In June 2026 (provisional), community service activity recorded 100,740 total contacts with Rother residents, of which 68,465 (68.0%) were with adults aged 65+. These borough-level figures reflect older-age community caseloads across the local authority, although activity for registered PCN patients was not captured.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Northiam Surgery1260.099.3%79.7%99.3%
    Oldwood Surgery1210.093.2%86.4%97.6%
    Martins Oak1210.086.0%79.3%93.5%
    Fairfield Surgery1020.084.1%68.2%88.4%
    Rye Medical Centre12423.287.4%82.7%88.3%
    Ferry Road10928.263.2%63.8%87.2%
    Sedlescombe &1160.061.3%78.5%80.6%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNRotherAssetPCNRother
    Care homes (catchment)20 (587 beds)n/aSchools (catchment)58n/a
    Children's centres12Places of worship71103
    Libraries23Food banks (VCS)23
    Homelessness support (VCS)02Day centres (VCS)2226
    Children and young people (VCS)56Primary schools (LA maintained)2323
    Primary academies59Special schools12

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review and prescribing audit

    Annual asthma review coverage is 62.9% (England 65.7%, Rother 59.1%) across 2,907 register patients (about 1,100 without a recorded review), while prescribing in ages 5-19 is 2,213 items per 1,000 (England 1,488). Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Secondary prevention lipid recall and review

    Statin therapy in diabetes with CVD fell 2.2% (England +1.0%) to 80.6% (England 84.4%) and lipid therapy for QRISK ≥ 20% is 60.0% (England 63.6%); lipid-modifying prescribing costs £2.90 per item (England £1.86), or £134,842 more than at England's unit cost across 129,656 items. Moderate effort to run.

    Evidence base: delivery measure for eight care processes and three treatment targets; shortfall here is what shows up later as emergency admission.

    Policy anchor: NHS Diabetes Prevention Programme and the eight care processes / three treatment targets.

    Option 3

    Dementia and learning disability register validation

    Three-year register growth trailed England in dementia (+2.7% vs +6.0%; prevalence 0.9% vs Rother 1.3%, modelled range -74 to +164 across 410 patients) and learning disability (+1.8% vs +5.4%; 0.6% vs Rother 0.7%, range +4 to +40 across 248 patients). Moderate effort to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older population multidisciplinary care planning (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 practice outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Physical health check recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension case finding review (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool immunisation recall audit (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephony and triage workflow review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · Structured asthma review and prescribing audit (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 PopulationCore20PLUS5 respiratoryPCN & Practice
    Option 2 · Secondary prevention lipid recall and review (p12)Patients with diabetes and a history of CVD (excl. haem. stroke) treated with a statin (denominator incl. PCAs) · Patients with QRISK ≥ 20% treated with lipid lowering therapy · Cost per item for Lipid-regulating drugs 2026NHS Long Term Plan (diabetes) and National Diabetes AuditPCN & Practice
    Option 3 · Dementia and learning disability register validation (p12)Learning disability register · Learning disability: QOF prevalence · Dementia register75% annual health checks (Network Contract DES) · Oliver McGowan · 66.7% diagnosis ambition · 95% care plan 2027PCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15